Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner. (Q46028496)
Jump to navigation
Jump to search
scientific article published on 4 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner. |
scientific article published on 4 May 2009 |
Statements
1 reference
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner. (English)
1 reference
Hisashi Adachi
1 reference
Tsukasa Nakamura
1 reference
Eiichi Sato
1 reference
Nobuharu Fujiwara
1 reference
Yasuhiro Kawagoe
1 reference
Yoshihiko Ueda
1 reference
Tsukasa Suzuki
1 reference
Seiji Ueda
1 reference
Seiya Okuda
1 reference
Sho-ichi Yamagishi
1 reference
4 May 2009
1 reference
60
1 reference
6
1 reference
525-528
1 reference